$Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia$

Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia

10.1155/2009/547582

Saved in:

Bibliographic Details
Main Authors:	Hwang, W.Y.K., Dearden, C., Loh, Y.S.M., Linn, Y.C., Tien, S.L., Teoh, G.K.H., How, G.F., Heng, K.K., Goh, Y.T., Lee, L.H.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/129913
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study
by: Hartmut Goldschmidt, et al.
Published: (2018)

Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
by: Lim, C.K., et al.
Published: (2016)

Impact of Postgrafting Immunosuppressive Regimens on Nonrelapse Mortality and Survival after Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant Using the Fludarabine and Low-Dose Total-Body Irradiation 200-cGy
by: Koh, L.-P., et al.
Published: (2011)

Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
by: Gupta, N, et al.
Published: (2020)

Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients
by: Pimjai Niparuck, et al.
Published: (2018)

Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
by: W. Bosch, et al.
Published: (2018)

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
by: Moreau, Philippe, et al.
Published: (2021)

Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia
by: Jassada Buaboonnam, et al.
Published: (2018)

RATIONAL DESIGN OF OPTIMISED THERAPEUTICS AGAINST RELAPSED / REFRACTORY NON-HODGKIN LYMPHOMA
by: GOH YA HWEE JASMINE
Published: (2023)

The use of alemtuzumab (Campath 1H) in organ transplant recipients
by: Calne, S.R.
Published: (2016)

Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma
by: Yoch Anongpornjossakul, et al.
Published: (2020)

Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes
by: Gullo, C.A, et al.
Published: (2020)

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
by: Chng, W-J, et al.
Published: (2022)

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation
by: Liu, X, et al.
Published: (2022)

Long-term follow-up of Asian patients younger than 46 years with acute myeloid leukemia in first complete remission: Comparison of allogeneic vs. autologous hematopoietic stem cell transplantation
by: Loh, Y.S.M., et al.
Published: (2011)

Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma)
by: Koh, M.J.-A., et al.
Published: (2016)

Vincristine therapy in refractory chronic idiopathic thrombocytopenic purpura
by: Kueh, Y.K.
Published: (2016)

Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
by: Vathsala, A, et al.
Published: (2022)

Non-bacterial infections in Asian patients treated with alemtuzumab: A retrospective study of the Asian Lymphoma Study Group
by: Seok Jin Kim, et al.
Published: (2018)

Use of phage display to isolate specific human monoclonal antibody fragments against a potential target for multiple myeloma
by: Pei, X.L., et al.
Published: (2016)

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network
by: Soekojo, Cinnie Yentia, et al.
Published: (2022)

Blood donation and beyond
by: Hwang, W.Y.K.
Published: (2016)

Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy
by: Jan Walewski, et al.
Published: (2019)

Induction of p53 Renders ATM-Deficient Mice Refractory to Hepatocarcinogenesis
by: Teoh, N., et al.
Published: (2011)

Refractory immune thrombocytopenia in systemic lupus erythematosus: Response to mycophenolate mofetil
by: Vasoo, S., et al.
Published: (2014)

Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: A case report
by: S. Jirasiritham, et al.
Published: (2018)

Paragonimus siamensis: Subcutaneous infection with ex-cysted metacercariae
by: J. Waikagul, et al.
Published: (2018)

Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse
by: Zee, Y.K., et al.
Published: (2014)

Subcutaneously administered recombinant human β-interferon in the treatment of chronic hepatitis B virus infection
by: Guan, R., et al.
Published: (2016)

Outpatient adult bronchial asthma in Singapore
by: Goh, L.G., et al.
Published: (2012)

Relapse
by: Nicholas J. White, et al.
Published: (2018)

Tumour infiltrating lymphocytes in nasopharyngeal carcinoma.
by: Chong, P.Y., et al.
Published: (2016)

Surgical treatment outcome of medically refractory huge giant papillary conjunctivitis
by: Lai, Y, et al.
Published: (2023)

Chemopreventive effect of Latobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse
by: Lim, B.-K., et al.
Published: (2011)

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: A single center experience from Thailand
by: Pimjai Niparuck, et al.
Published: (2018)

Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B-cell ALL
by: Somsak Prasongtanakij, et al.
Published: (2020)

Diode laser contact transscleral cyclophotocoagulation for refractory glaucoma in Asian patients
by: Wong, E.Y.M., et al.
Published: (2016)

Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: Current options and future potential
by: Hwang, W.Y.K., et al.
Published: (2016)

Automated segmentation of visceral, deep subcutaneous, and superficial subcutaneous adipose tissue volumes in MRI of neonates and young children
by: Kway, YM, et al.
Published: (2022)

Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients
by: Chan, T.S.-Y, et al.
Published: (2020)